Tanabe H, Suzuki T, Ohishi T, Isemura M, Nakamura Y, Unno K
Molecules. 2023; 28(2).
PMID: 36677584
PMC: 9862901.
DOI: 10.3390/molecules28020525.
Rezaei S, Azarpira N, Koohpeyma F, Yousefi R, Doaei S, Heidari M
Contemp Oncol (Pozn). 2022; 26(3):204-219.
PMID: 36381669
PMC: 9641631.
DOI: 10.5114/wo.2022.120700.
Justo B, Jasiulionis M
Int J Mol Sci. 2021; 22(17).
PMID: 34502227
PMC: 8431149.
DOI: 10.3390/ijms22179319.
Shantha Kumara H, Miyagaki H, Herath S, Pettke E, Yan X, Cekic V
World J Gastrointest Oncol. 2021; 13(8):879-892.
PMID: 34457193
PMC: 8371512.
DOI: 10.4251/wjgo.v13.i8.879.
Lee H, Jang Y, Park S, Jang H, Park E, Kim H
Theranostics. 2018; 8(15):4247-4261.
PMID: 30128051
PMC: 6096393.
DOI: 10.7150/thno.25131.
MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer.
Stene C, Polistena A, Gaber A, Nodin B, Ottochian B, Adawi D
In Vivo. 2017; 32(1):133-138.
PMID: 29275310
PMC: 5892640.
DOI: 10.21873/invivo.11215.
MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
Wei Z, Zhou C, Liu M, Yao Y, Sun J, Xiao J
Pituitary. 2015; 18(5):710-21.
PMID: 25862551
DOI: 10.1007/s11102-015-0648-3.
By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization.
Guan P, Yu X, Guo J, Wang Y, Wang T, Li J
Oncotarget. 2015; 6(11):9140-59.
PMID: 25823818
PMC: 4496208.
DOI: 10.18632/oncotarget.3274.
Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.
Elumalai P, Brindha Mercy A, Arunkamar R, Sharmila G, Bhat F, Balakrishnan S
Cell Prolif. 2014; 47(6):540-52.
PMID: 25377085
PMC: 6495824.
DOI: 10.1111/cpr.12148.
Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.
Wajner S, Capp C, Brasil B, Meurer L, Maia A
Oncol Lett. 2014; 7(3):731-737.
PMID: 24527080
PMC: 3919825.
DOI: 10.3892/ol.2013.1767.
Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic.
Stetler-Stevenson W, Gavil N
Connect Tissue Res. 2014; 55(1):13-9.
PMID: 24437600
PMC: 6309251.
DOI: 10.3109/03008207.2013.867339.
The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.
Shoji S, Nakano M, Sato H, Tang X, Osamura Y, Terachi T
Clin Exp Metastasis. 2013; 31(1):111-34.
PMID: 23959576
DOI: 10.1007/s10585-013-9612-7.
Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin.
Bao Q, Niess H, Djafarzadeh R, Zhao Y, Schwarz B, Angele M
Target Oncol. 2013; 9(3):251-61.
PMID: 23934106
PMC: 4156787.
DOI: 10.1007/s11523-013-0294-5.
TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells.
Bourboulia D, Han H, Jensen-Taubman S, Gavil N, Isaac B, Wei B
Oncotarget. 2013; 4(1):166-76.
PMID: 23371049
PMC: 3702216.
DOI: 10.18632/oncotarget.801.
Expression of the TIMP2 gene is not regulated by promoter hypermethylation in the Caski cell line.
Parashar G, Capalash N
Oncol Lett. 2012; 3(5):1079-1082.
PMID: 22783395
PMC: 3389666.
DOI: 10.3892/ol.2012.608.
TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain.
Jung Y, Liu X, Chirco R, Warner R, Fridman R, Kim H
PLoS One. 2012; 7(6):e38773.
PMID: 22701711
PMC: 3372473.
DOI: 10.1371/journal.pone.0038773.
The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.
Shin Y, Kim J
PLoS One. 2012; 7(1):e30393.
PMID: 22272343
PMC: 3260297.
DOI: 10.1371/journal.pone.0030393.
Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma.
Honkavuori-Toivola M, Talvensaari-Mattila A, Soini Y, Turpeenniemi-Hujanen T, Santala M
Tumour Biol. 2012; 33(4):935-41.
PMID: 22270451
DOI: 10.1007/s13277-012-0321-7.
Synovial expression of Th17-related and cancer-associated genes is regulated by the arthritis severity locus Cia10.
Jenkins E, Brenner M, Laragione T, Gulko P
Genes Immun. 2011; 13(3):221-31.
PMID: 22048456
PMC: 3339715.
DOI: 10.1038/gene.2011.73.
Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.
Bourboulia D, Jensen-Taubman S, Rittler M, Han H, Chatterjee T, Wei B
Am J Pathol. 2011; 179(5):2589-600.
PMID: 21933655
PMC: 3204083.
DOI: 10.1016/j.ajpath.2011.07.035.